Global Cancer Diagnostics Service Market Research Report 2026(Status and Outlook)
Cancer diagnostic services refer to medical technology services that utilize imaging examinations (such as CT, MRI, PET-CT) and in vitro diagnostics (including tumor marker detection, liquid biopsy, gene sequencing, pathological sections, and molecular subtyping) to provide early cancer screening, diagnosis, subtyping, staging, and medication guidance for suspected or high-risk individuals. This encompasses the entire process from sample collection and laboratory analysis to clinical interpretation. The upstream of the industry chain includes suppliers of high-throughput sequencers (Illumina, Thermo Fisher), antibody reagents, fluorescent probes, pathology equipment, AI-assisted diagnostic algorithms, and bioinformatics databases. The midstream consists of diagnostic service providers, who must possess CAP/CLIA or China National Institutes for Clinical Laboratories certification, NGS platforms, bioinformatics analysis capabilities, and compliant data management systems. The downstream primarily targets hospitals, health checkup centers, pharmaceutical companies (with companion diagnostics collaborations), and individual consumers. Due to its technology-intensive nature, high licensing barriers, and the inclusion of some services in medical insurance, the industry's overall gross profit margin is between 50% and 75%, with routine pathology and immunohistochemistry gross profit margins around 40%–60%, while NGS-based multi-cancer early screening or MRD monitoring services can achieve gross profit margins exceeding 70%.The Cancer Diagnostics Service market is expanding rapidly due to the rising global cancer incidence, aging populations, and increasing demand for early detection. Advances in molecular diagnostics, next-generation sequencing, and liquid biopsy technologies are transforming traditional cancer testing into more precise and less invasive approaches. Governments are strengthening cancer screening programs, while precision medicine is driving higher demand for companion diagnostics. Additionally, AI-powered imaging analysis and digital pathology platforms are improving diagnostic efficiency and accuracy. In the future, integrated multi-omics diagnostics and personalized cancer screening solutions will further drive sustained growth of the global cancer diagnostics service market.
The global Cancer Diagnostics Service market size was estimated at USD 39676.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 9.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cancer Diagnostics Service market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cancer Diagnostics Service market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cancer Diagnostics Service market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cancer Diagnostics Service Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cancer Diagnostics Service, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Cancer Diagnostics Service market size was estimated at USD 39676.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 9.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Cancer Diagnostics Service market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Cancer Diagnostics Service market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Cancer Diagnostics Service market.
Global Cancer Diagnostics Service Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Illumina
- BGI Genomics Co.,Ltd.
- Agilent Technologies
- Macrogen
- UCSF Health
- Abbott
- QIAGEN
- Siemens Healthcare GmbH
- Thermo Fisher Scientific, Inc.
- Applied DNA Sciences
- TherapySelect
- Caris Life Sciences
- Foresight Diagnostics
- Smartpraxis
- Amadix
- Check4Cancer
- Hologic
- RGCC
- ICON
Market Segmentation (by Type)
- Breast Cancer
- Blood Cancer
- Lung Cancer
- Colorectal Cancer
- Ovarian Cancer
- Others
Market Segmentation (by Application)
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Laboratories
- Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Cancer Diagnostics Service Market
Overview of the regional outlook of the Cancer Diagnostics Service Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Cancer Diagnostics Service Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Cancer Diagnostics Service, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Cancer Diagnostics Service
1.2 Key Market Segments
1.2.1 Cancer Diagnostics Service Segment by Type
1.2.2 Cancer Diagnostics Service Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANCER DIAGNOSTICS SERVICE MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANCER DIAGNOSTICS SERVICE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cancer Diagnostics Service Product Life Cycle
3.3 Global Cancer Diagnostics Service Revenue Market Share by Company (2020-2025)
3.4 Cancer Diagnostics Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Cancer Diagnostics Service Market Competitive Situation and Trends
3.6.1 Cancer Diagnostics Service Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cancer Diagnostics Service Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CANCER DIAGNOSTICS SERVICE VALUE CHAIN ANALYSIS
4.1 Cancer Diagnostics Service Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANCER DIAGNOSTICS SERVICE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cancer Diagnostics Service Market Porter's Five Forces Analysis
6 CANCER DIAGNOSTICS SERVICE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cancer Diagnostics Service Market by Type (2020-2025)
6.3 Global Cancer Diagnostics Service Market Size Growth Rate by Type (2021-2025)
7 CANCER DIAGNOSTICS SERVICE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cancer Diagnostics Service Market Size (M USD) by Application (2020-2025)
7.3 Global Cancer Diagnostics Service Market Size Growth Rate by Application (2021-2025)
8 CANCER DIAGNOSTICS SERVICE MARKET SEGMENTATION BY REGION
8.1 Global Cancer Diagnostics Service Market Size by Region
8.1.1 Global Cancer Diagnostics Service Market Size by Region
8.1.2 Global Cancer Diagnostics Service Market Size Market Share by Region
8.2 North America
8.2.1 North America Cancer Diagnostics Service Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cancer Diagnostics Service Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Cancer Diagnostics Service Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cancer Diagnostics Service Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cancer Diagnostics Service Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Illumina
9.1.1 Illumina Basic Information
9.1.2 Illumina Cancer Diagnostics Service Product Overview
9.1.3 Illumina Cancer Diagnostics Service Product Market Performance
9.1.4 Illumina SWOT Analysis
9.1.5 Illumina Business Overview
9.1.6 Illumina Recent Developments
9.2 BGI Genomics Co.,Ltd.
9.2.1 BGI Genomics Co.,Ltd. Basic Information
9.2.2 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product Overview
9.2.3 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product Market Performance
9.2.4 BGI Genomics Co.,Ltd. SWOT Analysis
9.2.5 BGI Genomics Co.,Ltd. Business Overview
9.2.6 BGI Genomics Co.,Ltd. Recent Developments
9.3 Agilent Technologies
9.3.1 Agilent Technologies Basic Information
9.3.2 Agilent Technologies Cancer Diagnostics Service Product Overview
9.3.3 Agilent Technologies Cancer Diagnostics Service Product Market Performance
9.3.4 Agilent Technologies SWOT Analysis
9.3.5 Agilent Technologies Business Overview
9.3.6 Agilent Technologies Recent Developments
9.4 Macrogen
9.4.1 Macrogen Basic Information
9.4.2 Macrogen Cancer Diagnostics Service Product Overview
9.4.3 Macrogen Cancer Diagnostics Service Product Market Performance
9.4.4 Macrogen Business Overview
9.4.5 Macrogen Recent Developments
9.5 UCSF Health
9.5.1 UCSF Health Basic Information
9.5.2 UCSF Health Cancer Diagnostics Service Product Overview
9.5.3 UCSF Health Cancer Diagnostics Service Product Market Performance
9.5.4 UCSF Health Business Overview
9.5.5 UCSF Health Recent Developments
9.6 Abbott
9.6.1 Abbott Basic Information
9.6.2 Abbott Cancer Diagnostics Service Product Overview
9.6.3 Abbott Cancer Diagnostics Service Product Market Performance
9.6.4 Abbott Business Overview
9.6.5 Abbott Recent Developments
9.7 QIAGEN
9.7.1 QIAGEN Basic Information
9.7.2 QIAGEN Cancer Diagnostics Service Product Overview
9.7.3 QIAGEN Cancer Diagnostics Service Product Market Performance
9.7.4 QIAGEN Business Overview
9.7.5 QIAGEN Recent Developments
9.8 Siemens Healthcare GmbH
9.8.1 Siemens Healthcare GmbH Basic Information
9.8.2 Siemens Healthcare GmbH Cancer Diagnostics Service Product Overview
9.8.3 Siemens Healthcare GmbH Cancer Diagnostics Service Product Market Performance
9.8.4 Siemens Healthcare GmbH Business Overview
9.8.5 Siemens Healthcare GmbH Recent Developments
9.9 Thermo Fisher Scientific, Inc.
9.9.1 Thermo Fisher Scientific, Inc. Basic Information
9.9.2 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product Overview
9.9.3 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product Market Performance
9.9.4 Thermo Fisher Scientific, Inc. Business Overview
9.9.5 Thermo Fisher Scientific, Inc. Recent Developments
9.10 Applied DNA Sciences
9.10.1 Applied DNA Sciences Basic Information
9.10.2 Applied DNA Sciences Cancer Diagnostics Service Product Overview
9.10.3 Applied DNA Sciences Cancer Diagnostics Service Product Market Performance
9.10.4 Applied DNA Sciences Business Overview
9.10.5 Applied DNA Sciences Recent Developments
9.11 TherapySelect
9.11.1 TherapySelect Basic Information
9.11.2 TherapySelect Cancer Diagnostics Service Product Overview
9.11.3 TherapySelect Cancer Diagnostics Service Product Market Performance
9.11.4 TherapySelect Business Overview
9.11.5 TherapySelect Recent Developments
9.12 Caris Life Sciences
9.12.1 Caris Life Sciences Basic Information
9.12.2 Caris Life Sciences Cancer Diagnostics Service Product Overview
9.12.3 Caris Life Sciences Cancer Diagnostics Service Product Market Performance
9.12.4 Caris Life Sciences Business Overview
9.12.5 Caris Life Sciences Recent Developments
9.13 Foresight Diagnostics
9.13.1 Foresight Diagnostics Basic Information
9.13.2 Foresight Diagnostics Cancer Diagnostics Service Product Overview
9.13.3 Foresight Diagnostics Cancer Diagnostics Service Product Market Performance
9.13.4 Foresight Diagnostics Business Overview
9.13.5 Foresight Diagnostics Recent Developments
9.14 Smartpraxis
9.14.1 Smartpraxis Basic Information
9.14.2 Smartpraxis Cancer Diagnostics Service Product Overview
9.14.3 Smartpraxis Cancer Diagnostics Service Product Market Performance
9.14.4 Smartpraxis Business Overview
9.14.5 Smartpraxis Recent Developments
9.15 Amadix
9.15.1 Amadix Basic Information
9.15.2 Amadix Cancer Diagnostics Service Product Overview
9.15.3 Amadix Cancer Diagnostics Service Product Market Performance
9.15.4 Amadix Business Overview
9.15.5 Amadix Recent Developments
9.16 Check4Cancer
9.16.1 Check4Cancer Basic Information
9.16.2 Check4Cancer Cancer Diagnostics Service Product Overview
9.16.3 Check4Cancer Cancer Diagnostics Service Product Market Performance
9.16.4 Check4Cancer Business Overview
9.16.5 Check4Cancer Recent Developments
9.17 Hologic
9.17.1 Hologic Basic Information
9.17.2 Hologic Cancer Diagnostics Service Product Overview
9.17.3 Hologic Cancer Diagnostics Service Product Market Performance
9.17.4 Hologic Business Overview
9.17.5 Hologic Recent Developments
9.18 RGCC
9.18.1 RGCC Basic Information
9.18.2 RGCC Cancer Diagnostics Service Product Overview
9.18.3 RGCC Cancer Diagnostics Service Product Market Performance
9.18.4 RGCC Business Overview
9.18.5 RGCC Recent Developments
9.19 ICON
9.19.1 ICON Basic Information
9.19.2 ICON Cancer Diagnostics Service Product Overview
9.19.3 ICON Cancer Diagnostics Service Product Market Performance
9.19.4 ICON Business Overview
9.19.5 ICON Recent Developments
10 CANCER DIAGNOSTICS SERVICE MARKET FORECAST BY REGION
10.1 Global Cancer Diagnostics Service Market Size Forecast
10.2 Global Cancer Diagnostics Service Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cancer Diagnostics Service Market Size Forecast by Country
10.2.3 Asia Pacific Cancer Diagnostics Service Market Size Forecast by Region
10.2.4 South America Cancer Diagnostics Service Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Cancer Diagnostics Service by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Cancer Diagnostics Service Market Forecast by Type (2026-2035)
11.1.1 Global Cancer Diagnostics Service Market Size Forecast by Type (2026-2035)
11.2 Global Cancer Diagnostics Service Market Forecast by Application (2026-2035)
11.2.1 Global Cancer Diagnostics Service Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Cancer Diagnostics Service
1.2 Key Market Segments
1.2.1 Cancer Diagnostics Service Segment by Type
1.2.2 Cancer Diagnostics Service Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CANCER DIAGNOSTICS SERVICE MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CANCER DIAGNOSTICS SERVICE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Cancer Diagnostics Service Product Life Cycle
3.3 Global Cancer Diagnostics Service Revenue Market Share by Company (2020-2025)
3.4 Cancer Diagnostics Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Headquarters, Areas Served, and Product Types of Major Players
3.6 Cancer Diagnostics Service Market Competitive Situation and Trends
3.6.1 Cancer Diagnostics Service Market Concentration Rate
3.6.2 Global 5 and 10 Largest Cancer Diagnostics Service Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CANCER DIAGNOSTICS SERVICE VALUE CHAIN ANALYSIS
4.1 Cancer Diagnostics Service Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CANCER DIAGNOSTICS SERVICE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Cancer Diagnostics Service Market Porter's Five Forces Analysis
6 CANCER DIAGNOSTICS SERVICE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Cancer Diagnostics Service Market by Type (2020-2025)
6.3 Global Cancer Diagnostics Service Market Size Growth Rate by Type (2021-2025)
7 CANCER DIAGNOSTICS SERVICE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Cancer Diagnostics Service Market Size (M USD) by Application (2020-2025)
7.3 Global Cancer Diagnostics Service Market Size Growth Rate by Application (2021-2025)
8 CANCER DIAGNOSTICS SERVICE MARKET SEGMENTATION BY REGION
8.1 Global Cancer Diagnostics Service Market Size by Region
8.1.1 Global Cancer Diagnostics Service Market Size by Region
8.1.2 Global Cancer Diagnostics Service Market Size Market Share by Region
8.2 North America
8.2.1 North America Cancer Diagnostics Service Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Cancer Diagnostics Service Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Cancer Diagnostics Service Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Cancer Diagnostics Service Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Cancer Diagnostics Service Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Illumina
9.1.1 Illumina Basic Information
9.1.2 Illumina Cancer Diagnostics Service Product Overview
9.1.3 Illumina Cancer Diagnostics Service Product Market Performance
9.1.4 Illumina SWOT Analysis
9.1.5 Illumina Business Overview
9.1.6 Illumina Recent Developments
9.2 BGI Genomics Co.,Ltd.
9.2.1 BGI Genomics Co.,Ltd. Basic Information
9.2.2 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product Overview
9.2.3 BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product Market Performance
9.2.4 BGI Genomics Co.,Ltd. SWOT Analysis
9.2.5 BGI Genomics Co.,Ltd. Business Overview
9.2.6 BGI Genomics Co.,Ltd. Recent Developments
9.3 Agilent Technologies
9.3.1 Agilent Technologies Basic Information
9.3.2 Agilent Technologies Cancer Diagnostics Service Product Overview
9.3.3 Agilent Technologies Cancer Diagnostics Service Product Market Performance
9.3.4 Agilent Technologies SWOT Analysis
9.3.5 Agilent Technologies Business Overview
9.3.6 Agilent Technologies Recent Developments
9.4 Macrogen
9.4.1 Macrogen Basic Information
9.4.2 Macrogen Cancer Diagnostics Service Product Overview
9.4.3 Macrogen Cancer Diagnostics Service Product Market Performance
9.4.4 Macrogen Business Overview
9.4.5 Macrogen Recent Developments
9.5 UCSF Health
9.5.1 UCSF Health Basic Information
9.5.2 UCSF Health Cancer Diagnostics Service Product Overview
9.5.3 UCSF Health Cancer Diagnostics Service Product Market Performance
9.5.4 UCSF Health Business Overview
9.5.5 UCSF Health Recent Developments
9.6 Abbott
9.6.1 Abbott Basic Information
9.6.2 Abbott Cancer Diagnostics Service Product Overview
9.6.3 Abbott Cancer Diagnostics Service Product Market Performance
9.6.4 Abbott Business Overview
9.6.5 Abbott Recent Developments
9.7 QIAGEN
9.7.1 QIAGEN Basic Information
9.7.2 QIAGEN Cancer Diagnostics Service Product Overview
9.7.3 QIAGEN Cancer Diagnostics Service Product Market Performance
9.7.4 QIAGEN Business Overview
9.7.5 QIAGEN Recent Developments
9.8 Siemens Healthcare GmbH
9.8.1 Siemens Healthcare GmbH Basic Information
9.8.2 Siemens Healthcare GmbH Cancer Diagnostics Service Product Overview
9.8.3 Siemens Healthcare GmbH Cancer Diagnostics Service Product Market Performance
9.8.4 Siemens Healthcare GmbH Business Overview
9.8.5 Siemens Healthcare GmbH Recent Developments
9.9 Thermo Fisher Scientific, Inc.
9.9.1 Thermo Fisher Scientific, Inc. Basic Information
9.9.2 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product Overview
9.9.3 Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product Market Performance
9.9.4 Thermo Fisher Scientific, Inc. Business Overview
9.9.5 Thermo Fisher Scientific, Inc. Recent Developments
9.10 Applied DNA Sciences
9.10.1 Applied DNA Sciences Basic Information
9.10.2 Applied DNA Sciences Cancer Diagnostics Service Product Overview
9.10.3 Applied DNA Sciences Cancer Diagnostics Service Product Market Performance
9.10.4 Applied DNA Sciences Business Overview
9.10.5 Applied DNA Sciences Recent Developments
9.11 TherapySelect
9.11.1 TherapySelect Basic Information
9.11.2 TherapySelect Cancer Diagnostics Service Product Overview
9.11.3 TherapySelect Cancer Diagnostics Service Product Market Performance
9.11.4 TherapySelect Business Overview
9.11.5 TherapySelect Recent Developments
9.12 Caris Life Sciences
9.12.1 Caris Life Sciences Basic Information
9.12.2 Caris Life Sciences Cancer Diagnostics Service Product Overview
9.12.3 Caris Life Sciences Cancer Diagnostics Service Product Market Performance
9.12.4 Caris Life Sciences Business Overview
9.12.5 Caris Life Sciences Recent Developments
9.13 Foresight Diagnostics
9.13.1 Foresight Diagnostics Basic Information
9.13.2 Foresight Diagnostics Cancer Diagnostics Service Product Overview
9.13.3 Foresight Diagnostics Cancer Diagnostics Service Product Market Performance
9.13.4 Foresight Diagnostics Business Overview
9.13.5 Foresight Diagnostics Recent Developments
9.14 Smartpraxis
9.14.1 Smartpraxis Basic Information
9.14.2 Smartpraxis Cancer Diagnostics Service Product Overview
9.14.3 Smartpraxis Cancer Diagnostics Service Product Market Performance
9.14.4 Smartpraxis Business Overview
9.14.5 Smartpraxis Recent Developments
9.15 Amadix
9.15.1 Amadix Basic Information
9.15.2 Amadix Cancer Diagnostics Service Product Overview
9.15.3 Amadix Cancer Diagnostics Service Product Market Performance
9.15.4 Amadix Business Overview
9.15.5 Amadix Recent Developments
9.16 Check4Cancer
9.16.1 Check4Cancer Basic Information
9.16.2 Check4Cancer Cancer Diagnostics Service Product Overview
9.16.3 Check4Cancer Cancer Diagnostics Service Product Market Performance
9.16.4 Check4Cancer Business Overview
9.16.5 Check4Cancer Recent Developments
9.17 Hologic
9.17.1 Hologic Basic Information
9.17.2 Hologic Cancer Diagnostics Service Product Overview
9.17.3 Hologic Cancer Diagnostics Service Product Market Performance
9.17.4 Hologic Business Overview
9.17.5 Hologic Recent Developments
9.18 RGCC
9.18.1 RGCC Basic Information
9.18.2 RGCC Cancer Diagnostics Service Product Overview
9.18.3 RGCC Cancer Diagnostics Service Product Market Performance
9.18.4 RGCC Business Overview
9.18.5 RGCC Recent Developments
9.19 ICON
9.19.1 ICON Basic Information
9.19.2 ICON Cancer Diagnostics Service Product Overview
9.19.3 ICON Cancer Diagnostics Service Product Market Performance
9.19.4 ICON Business Overview
9.19.5 ICON Recent Developments
10 CANCER DIAGNOSTICS SERVICE MARKET FORECAST BY REGION
10.1 Global Cancer Diagnostics Service Market Size Forecast
10.2 Global Cancer Diagnostics Service Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Cancer Diagnostics Service Market Size Forecast by Country
10.2.3 Asia Pacific Cancer Diagnostics Service Market Size Forecast by Region
10.2.4 South America Cancer Diagnostics Service Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Cancer Diagnostics Service by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
11.1 Global Cancer Diagnostics Service Market Forecast by Type (2026-2035)
11.1.1 Global Cancer Diagnostics Service Market Size Forecast by Type (2026-2035)
11.2 Global Cancer Diagnostics Service Market Forecast by Application (2026-2035)
11.2.1 Global Cancer Diagnostics Service Market Size (M USD) Forecast by Application (2026-2035)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cancer Diagnostics Service Market Size by Type (M USD)
Table 4. Global Cancer Diagnostics Service Market Size by Application
Table 5. Cancer Diagnostics Service Market Size Comparison by Region (M USD)
Table 6. Global Cancer Diagnostics Service Revenue (M USD) by Company (2020-2025)
Table 7. Global Cancer Diagnostics Service Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Diagnostics Service as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Cancer Diagnostics Service Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Cancer Diagnostics Service Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Cancer Diagnostics Service Market Size by Type (M USD)
Table 22. Global Cancer Diagnostics Service Market Size (M USD) by Type (2020-2025)
Table 23. Global Cancer Diagnostics Service Market Share by Type (2020-2025)
Table 24. Global Cancer Diagnostics Service Market Size Growth Rate by Type (2021-2025)
Table 25. Global Cancer Diagnostics Service Market Size by Application
Table 26. Global Cancer Diagnostics Service Market Size by Application (2020-2025) & (M USD)
Table 27. Global Cancer Diagnostics Service Market Share by Application (2020-2025)
Table 28. Global Cancer Diagnostics Service Market Size Growth Rate by Application (2021-2025)
Table 29. Global Cancer Diagnostics Service Market Size by Region (2020-2025) & (M USD)
Table 30. Global Cancer Diagnostics Service Market Size Market Share by Region (2020-2025)
Table 31. North America Cancer Diagnostics Service Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Cancer Diagnostics Service Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Cancer Diagnostics Service Market Size by Region (2020-2025) & (M USD)
Table 34. South America Cancer Diagnostics Service Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Cancer Diagnostics Service Market Size by Region (2020-2025) & (M USD)
Table 36. Illumina Basic Information
Table 37. Illumina Cancer Diagnostics Service Product Overview
Table 38. Illumina Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Illumina SWOT Analysis
Table 40. Illumina Business Overview
Table 41. Illumina Recent Developments
Table 42. BGI Genomics Co.,Ltd. Basic Information
Table 43. BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product Overview
Table 44. BGI Genomics Co.,Ltd. Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 45. BGI Genomics Co.,Ltd. SWOT Analysis
Table 46. BGI Genomics Co.,Ltd. Business Overview
Table 47. BGI Genomics Co.,Ltd. Recent Developments
Table 48. Agilent Technologies Basic Information
Table 49. Agilent Technologies Cancer Diagnostics Service Product Overview
Table 50. Agilent Technologies Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Agilent Technologies SWOT Analysis
Table 52. Agilent Technologies Business Overview
Table 53. Agilent Technologies Recent Developments
Table 54. Macrogen Basic Information
Table 55. Macrogen Cancer Diagnostics Service Product Overview
Table 56. Macrogen Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Macrogen Business Overview
Table 58. Macrogen Recent Developments
Table 59. UCSF Health Basic Information
Table 60. UCSF Health Cancer Diagnostics Service Product Overview
Table 61. UCSF Health Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 62. UCSF Health Business Overview
Table 63. UCSF Health Recent Developments
Table 64. Abbott Basic Information
Table 65. Abbott Cancer Diagnostics Service Product Overview
Table 66. Abbott Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Abbott Business Overview
Table 68. Abbott Recent Developments
Table 69. QIAGEN Basic Information
Table 70. QIAGEN Cancer Diagnostics Service Product Overview
Table 71. QIAGEN Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 72. QIAGEN Business Overview
Table 73. QIAGEN Recent Developments
Table 74. Siemens Healthcare GmbH Basic Information
Table 75. Siemens Healthcare GmbH Cancer Diagnostics Service Product Overview
Table 76. Siemens Healthcare GmbH Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Siemens Healthcare GmbH Business Overview
Table 78. Siemens Healthcare GmbH Recent Developments
Table 79. Thermo Fisher Scientific, Inc. Basic Information
Table 80. Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product Overview
Table 81. Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Thermo Fisher Scientific, Inc. Business Overview
Table 83. Thermo Fisher Scientific, Inc. Recent Developments
Table 84. Applied DNA Sciences Basic Information
Table 85. Applied DNA Sciences Cancer Diagnostics Service Product Overview
Table 86. Applied DNA Sciences Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Applied DNA Sciences Business Overview
Table 88. Applied DNA Sciences Recent Developments
Table 89. TherapySelect Basic Information
Table 90. TherapySelect Cancer Diagnostics Service Product Overview
Table 91. TherapySelect Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 92. TherapySelect Business Overview
Table 93. TherapySelect Recent Developments
Table 94. Caris Life Sciences Basic Information
Table 95. Caris Life Sciences Cancer Diagnostics Service Product Overview
Table 96. Caris Life Sciences Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 97. Caris Life Sciences Business Overview
Table 98. Caris Life Sciences Recent Developments
Table 99. Foresight Diagnostics Basic Information
Table 100. Foresight Diagnostics Cancer Diagnostics Service Product Overview
Table 101. Foresight Diagnostics Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Foresight Diagnostics Business Overview
Table 103. Foresight Diagnostics Recent Developments
Table 104. Smartpraxis Basic Information
Table 105. Smartpraxis Cancer Diagnostics Service Product Overview
Table 106. Smartpraxis Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Smartpraxis Business Overview
Table 108. Smartpraxis Recent Developments
Table 109. Amadix Basic Information
Table 110. Amadix Cancer Diagnostics Service Product Overview
Table 111. Amadix Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Amadix Business Overview
Table 113. Amadix Recent Developments
Table 114. Check4Cancer Basic Information
Table 115. Check4Cancer Cancer Diagnostics Service Product Overview
Table 116. Check4Cancer Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Check4Cancer Business Overview
Table 118. Check4Cancer Recent Developments
Table 119. Hologic Basic Information
Table 120. Hologic Cancer Diagnostics Service Product Overview
Table 121. Hologic Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 122. Hologic Business Overview
Table 123. Hologic Recent Developments
Table 124. RGCC Basic Information
Table 125. RGCC Cancer Diagnostics Service Product Overview
Table 126. RGCC Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 127. RGCC Business Overview
Table 128. RGCC Recent Developments
Table 129. ICON Basic Information
Table 130. ICON Cancer Diagnostics Service Product Overview
Table 131. ICON Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 132. ICON Business Overview
Table 133. ICON Recent Developments
Table 134. Global Cancer Diagnostics Service Market Size Forecast by Region (2026-2035) & (M USD)
Table 135. North America Cancer Diagnostics Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Europe Cancer Diagnostics Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Asia Pacific Cancer Diagnostics Service Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America Cancer Diagnostics Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Middle East and Africa Cancer Diagnostics Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Global Cancer Diagnostics Service Market Size Forecast by Type (2026-2035) & (M USD)
Table 141. Global Cancer Diagnostics Service Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Cancer Diagnostics Service Market Size by Type (M USD)
Table 4. Global Cancer Diagnostics Service Market Size by Application
Table 5. Cancer Diagnostics Service Market Size Comparison by Region (M USD)
Table 6. Global Cancer Diagnostics Service Revenue (M USD) by Company (2020-2025)
Table 7. Global Cancer Diagnostics Service Revenue Share by Company (2020-2025)
Table 8. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Diagnostics Service as of 2025)
Table 9. Headquarters, Areas Served, and Product Types of Major Players
Table 10. Product Type of Major Players
Table 11. Global Cancer Diagnostics Service Company Market Concentration Ratio (CR5 and HHI)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Midstream Market Analysis
Table 14. Downstream Customer Analysis
Table 15. Key Development Trends
Table 16. Driving Factors
Table 17. Cancer Diagnostics Service Market Challenges
Table 18. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 19. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 20. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 21. Global Cancer Diagnostics Service Market Size by Type (M USD)
Table 22. Global Cancer Diagnostics Service Market Size (M USD) by Type (2020-2025)
Table 23. Global Cancer Diagnostics Service Market Share by Type (2020-2025)
Table 24. Global Cancer Diagnostics Service Market Size Growth Rate by Type (2021-2025)
Table 25. Global Cancer Diagnostics Service Market Size by Application
Table 26. Global Cancer Diagnostics Service Market Size by Application (2020-2025) & (M USD)
Table 27. Global Cancer Diagnostics Service Market Share by Application (2020-2025)
Table 28. Global Cancer Diagnostics Service Market Size Growth Rate by Application (2021-2025)
Table 29. Global Cancer Diagnostics Service Market Size by Region (2020-2025) & (M USD)
Table 30. Global Cancer Diagnostics Service Market Size Market Share by Region (2020-2025)
Table 31. North America Cancer Diagnostics Service Market Size by Country (2020-2025) & (M USD)
Table 32. Europe Cancer Diagnostics Service Market Size by Country (2020-2025) & (M USD)
Table 33. Asia Pacific Cancer Diagnostics Service Market Size by Region (2020-2025) & (M USD)
Table 34. South America Cancer Diagnostics Service Market Size by Country (2020-2025) & (M USD)
Table 35. Middle East and Africa Cancer Diagnostics Service Market Size by Region (2020-2025) & (M USD)
Table 36. Illumina Basic Information
Table 37. Illumina Cancer Diagnostics Service Product Overview
Table 38. Illumina Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 39. Illumina SWOT Analysis
Table 40. Illumina Business Overview
Table 41. Illumina Recent Developments
Table 42. BGI Genomics Co.,Ltd. Basic Information
Table 43. BGI Genomics Co.,Ltd. Cancer Diagnostics Service Product Overview
Table 44. BGI Genomics Co.,Ltd. Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 45. BGI Genomics Co.,Ltd. SWOT Analysis
Table 46. BGI Genomics Co.,Ltd. Business Overview
Table 47. BGI Genomics Co.,Ltd. Recent Developments
Table 48. Agilent Technologies Basic Information
Table 49. Agilent Technologies Cancer Diagnostics Service Product Overview
Table 50. Agilent Technologies Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 51. Agilent Technologies SWOT Analysis
Table 52. Agilent Technologies Business Overview
Table 53. Agilent Technologies Recent Developments
Table 54. Macrogen Basic Information
Table 55. Macrogen Cancer Diagnostics Service Product Overview
Table 56. Macrogen Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 57. Macrogen Business Overview
Table 58. Macrogen Recent Developments
Table 59. UCSF Health Basic Information
Table 60. UCSF Health Cancer Diagnostics Service Product Overview
Table 61. UCSF Health Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 62. UCSF Health Business Overview
Table 63. UCSF Health Recent Developments
Table 64. Abbott Basic Information
Table 65. Abbott Cancer Diagnostics Service Product Overview
Table 66. Abbott Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 67. Abbott Business Overview
Table 68. Abbott Recent Developments
Table 69. QIAGEN Basic Information
Table 70. QIAGEN Cancer Diagnostics Service Product Overview
Table 71. QIAGEN Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 72. QIAGEN Business Overview
Table 73. QIAGEN Recent Developments
Table 74. Siemens Healthcare GmbH Basic Information
Table 75. Siemens Healthcare GmbH Cancer Diagnostics Service Product Overview
Table 76. Siemens Healthcare GmbH Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 77. Siemens Healthcare GmbH Business Overview
Table 78. Siemens Healthcare GmbH Recent Developments
Table 79. Thermo Fisher Scientific, Inc. Basic Information
Table 80. Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Product Overview
Table 81. Thermo Fisher Scientific, Inc. Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 82. Thermo Fisher Scientific, Inc. Business Overview
Table 83. Thermo Fisher Scientific, Inc. Recent Developments
Table 84. Applied DNA Sciences Basic Information
Table 85. Applied DNA Sciences Cancer Diagnostics Service Product Overview
Table 86. Applied DNA Sciences Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 87. Applied DNA Sciences Business Overview
Table 88. Applied DNA Sciences Recent Developments
Table 89. TherapySelect Basic Information
Table 90. TherapySelect Cancer Diagnostics Service Product Overview
Table 91. TherapySelect Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 92. TherapySelect Business Overview
Table 93. TherapySelect Recent Developments
Table 94. Caris Life Sciences Basic Information
Table 95. Caris Life Sciences Cancer Diagnostics Service Product Overview
Table 96. Caris Life Sciences Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 97. Caris Life Sciences Business Overview
Table 98. Caris Life Sciences Recent Developments
Table 99. Foresight Diagnostics Basic Information
Table 100. Foresight Diagnostics Cancer Diagnostics Service Product Overview
Table 101. Foresight Diagnostics Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 102. Foresight Diagnostics Business Overview
Table 103. Foresight Diagnostics Recent Developments
Table 104. Smartpraxis Basic Information
Table 105. Smartpraxis Cancer Diagnostics Service Product Overview
Table 106. Smartpraxis Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 107. Smartpraxis Business Overview
Table 108. Smartpraxis Recent Developments
Table 109. Amadix Basic Information
Table 110. Amadix Cancer Diagnostics Service Product Overview
Table 111. Amadix Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 112. Amadix Business Overview
Table 113. Amadix Recent Developments
Table 114. Check4Cancer Basic Information
Table 115. Check4Cancer Cancer Diagnostics Service Product Overview
Table 116. Check4Cancer Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 117. Check4Cancer Business Overview
Table 118. Check4Cancer Recent Developments
Table 119. Hologic Basic Information
Table 120. Hologic Cancer Diagnostics Service Product Overview
Table 121. Hologic Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 122. Hologic Business Overview
Table 123. Hologic Recent Developments
Table 124. RGCC Basic Information
Table 125. RGCC Cancer Diagnostics Service Product Overview
Table 126. RGCC Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 127. RGCC Business Overview
Table 128. RGCC Recent Developments
Table 129. ICON Basic Information
Table 130. ICON Cancer Diagnostics Service Product Overview
Table 131. ICON Cancer Diagnostics Service Revenue (M USD) and Gross Margin (2020-2025)
Table 132. ICON Business Overview
Table 133. ICON Recent Developments
Table 134. Global Cancer Diagnostics Service Market Size Forecast by Region (2026-2035) & (M USD)
Table 135. North America Cancer Diagnostics Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 136. Europe Cancer Diagnostics Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Asia Pacific Cancer Diagnostics Service Market Size Forecast by Region (2026-2035) & (M USD)
Table 138. South America Cancer Diagnostics Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Middle East and Africa Cancer Diagnostics Service Market Size Forecast by Country (2026-2035) & (M USD)
Table 140. Global Cancer Diagnostics Service Market Size Forecast by Type (2026-2035) & (M USD)
Table 141. Global Cancer Diagnostics Service Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Cancer Diagnostics Service
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cancer Diagnostics Service Market Size (M USD), 2025-2035
Figure 5. Global Cancer Diagnostics Service Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Cancer Diagnostics Service Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Cancer Diagnostics Service Product Life Cycle
Figure 12. Global Cancer Diagnostics Service Revenue Share by Company in 2025
Figure 13. Cancer Diagnostics Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Cancer Diagnostics Service Revenue in 2025
Figure 15. Value Chain Map of Cancer Diagnostics Service
Figure 16. Global Cancer Diagnostics Service Market PEST Analysis
Figure 17. Global Cancer Diagnostics Service Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Cancer Diagnostics Service Market Share by Type
Figure 20. Market Share of Cancer Diagnostics Service by Type (2020-2025)
Figure 21. Global Cancer Diagnostics Service Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cancer Diagnostics Service Market Share by Application
Figure 24. Global Cancer Diagnostics Service Market Share by Application (2020-2025)
Figure 25. Global Cancer Diagnostics Service Market Share by Application in 2024
Figure 26. Global Cancer Diagnostics Service Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Cancer Diagnostics Service Market Size Market Share by Region (2020-2025)
Figure 28. North America Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Cancer Diagnostics Service Market Size Market Share by Country in 2024
Figure 30. U.S. Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Cancer Diagnostics Service Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Cancer Diagnostics Service Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Cancer Diagnostics Service Market Share by Country in 2024
Figure 35. Germany Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Cancer Diagnostics Service Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Cancer Diagnostics Service Market Size Market Share by Region in 2024
Figure 42. China Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Cancer Diagnostics Service Market Size and Growth Rate (M USD)
Figure 48. South America Cancer Diagnostics Service Market Size Market Share by Country in 2024
Figure 49. Brazil Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Cancer Diagnostics Service Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Cancer Diagnostics Service Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Cancer Diagnostics Service Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Cancer Diagnostics Service Market Share Forecast by Type (2026-2035)
Figure 61. Global Cancer Diagnostics Service Market Share Forecast by Application (2026-2035)
Figure 1. Industry Chain of Cancer Diagnostics Service
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Cancer Diagnostics Service Market Size (M USD), 2025-2035
Figure 5. Global Cancer Diagnostics Service Market Size (M USD) (2020-2035)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Cancer Diagnostics Service Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Cancer Diagnostics Service Product Life Cycle
Figure 12. Global Cancer Diagnostics Service Revenue Share by Company in 2025
Figure 13. Cancer Diagnostics Service Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Cancer Diagnostics Service Revenue in 2025
Figure 15. Value Chain Map of Cancer Diagnostics Service
Figure 16. Global Cancer Diagnostics Service Market PEST Analysis
Figure 17. Global Cancer Diagnostics Service Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Cancer Diagnostics Service Market Share by Type
Figure 20. Market Share of Cancer Diagnostics Service by Type (2020-2025)
Figure 21. Global Cancer Diagnostics Service Market Size Growth Rate by Type (2021-2025)
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Cancer Diagnostics Service Market Share by Application
Figure 24. Global Cancer Diagnostics Service Market Share by Application (2020-2025)
Figure 25. Global Cancer Diagnostics Service Market Share by Application in 2024
Figure 26. Global Cancer Diagnostics Service Market Size Growth Rate by Application (2021-2025)
Figure 27. Global Cancer Diagnostics Service Market Size Market Share by Region (2020-2025)
Figure 28. North America Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 29. North America Cancer Diagnostics Service Market Size Market Share by Country in 2024
Figure 30. U.S. Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 31. Canada Cancer Diagnostics Service Market Size (M USD) and Growth Rate (2020-2025)
Figure 32. Mexico Cancer Diagnostics Service Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Europe Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 34. Europe Cancer Diagnostics Service Market Share by Country in 2024
Figure 35. Germany Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 36. France Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. U.K. Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. Italy Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Spain Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Asia Pacific Cancer Diagnostics Service Market Size and Growth Rate (M USD)
Figure 41. Asia Pacific Cancer Diagnostics Service Market Size Market Share by Region in 2024
Figure 42. China Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. Japan Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. South Korea Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. India Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Southeast Asia Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. South America Cancer Diagnostics Service Market Size and Growth Rate (M USD)
Figure 48. South America Cancer Diagnostics Service Market Size Market Share by Country in 2024
Figure 49. Brazil Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 50. Argentina Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Columbia Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Middle East and Africa Cancer Diagnostics Service Market Size and Growth Rate (M USD)
Figure 53. Middle East and Africa Cancer Diagnostics Service Market Size Market Share by Region in 2024
Figure 54. Saudi Arabia Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 55. UAE Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. Egypt Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Nigeria Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. South Africa Cancer Diagnostics Service Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. Global Cancer Diagnostics Service Market Size Forecast by Value (2020-2035) & (M USD)
Figure 60. Global Cancer Diagnostics Service Market Share Forecast by Type (2026-2035)
Figure 61. Global Cancer Diagnostics Service Market Share Forecast by Application (2026-2035)